小儿患者静脉血栓栓塞症的治疗
Treatment of Venous Thromboembolism in Pediatric Patients.
作者信息
Malec Lynn, Young Guy
机构信息
BloodCenter of Wisconsin, Milwaukee, WI, USA; Medical College of Wisconsin, Milwaukee, WI, USA.
Department of Pediatrics, Division of Hematology, Children's Hospital of Los Angeles , Los Angeles, CA , USA.
出版信息
Front Pediatr. 2017 Feb 28;5:26. doi: 10.3389/fped.2017.00026. eCollection 2017.
Abstract
Given the increased incidence of venous thromboembolism (VTE) in pediatric patients, which has been associated with increased survival of medically complex patients and increased use of invasive supportive measures, it is important to understand treatment options and unique aspects of anticoagulant use in children. The objective of this mini-review is to outline the goals of treatment, treatment options, and adverse events associated with the use of anticoagulants in pediatric patients with VTE.
摘要
鉴于儿科患者静脉血栓栓塞症（VTE）的发病率增加，这与病情复杂患者的生存率提高以及侵入性支持措施的使用增加有关，了解儿童的治疗选择和抗凝剂使用的独特方面非常重要。本小型综述的目的是概述VTE儿科患者使用抗凝剂的治疗目标、治疗选择和不良事件。
相似文献
1
Treatment of Venous Thromboembolism in Pediatric Patients.小儿患者静脉血栓栓塞症的治疗
Front Pediatr. 2017 Feb 28;5:26. doi: 10.3389/fped.2017.00026. eCollection 2017.
2
Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.儿童静脉血栓栓塞症抗凝治疗的持续时间：当前方法及随机对照试验的更新情况
Expert Rev Hematol. 2018 Jan;11(1):37-44. doi: 10.1080/17474086.2018.1407241. Epub 2017 Dec 17.
3
4
Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.小儿创伤患者的静脉血栓栓塞：三级医疗中心的十年经验及长期随访
Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26415. Epub 2017 Jan 9.
5
Pediatric venous thromboembolism in relation to adults.儿科静脉血栓栓塞与成人相关。
J Vasc Surg. 2012 Jun;55(6):1785-93. doi: 10.1016/j.jvs.2011.07.047. Epub 2011 Sep 23.
6
Risk factors for venous thromboembolism in children.儿童静脉血栓栓塞的危险因素。
Int Angiol. 2004 Sep;23(3):195-205.
7
Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.医学疾病患者的静脉血栓栓塞预防：混合治疗比较荟萃分析。
J Thromb Thrombolysis. 2018 Jan;45(1):36-47. doi: 10.1007/s11239-017-1562-5.
8
Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.25 年来单一中心儿科肿瘤患者静脉血栓栓塞发生率和复发率的增加。
Thromb Haemost. 2017 Nov;117(11):2156-2162. doi: 10.1160/TH17-02-0109. Epub 2017 Nov 30.
9
Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.采用混合治疗比较的荟萃分析方法评估口服抗凝剂用于静脉血栓栓塞症的长期治疗。
Clin Ther. 2014 Oct 1;36(10):1454-64.e3. doi: 10.1016/j.clinthera.2014.06.033. Epub 2014 Aug 3.
10
Pediatric Hospital Acquired Venous Thromboembolism.儿科医院获得性静脉血栓栓塞症
Front Pediatr. 2017 Sep 19;5:198. doi: 10.3389/fped.2017.00198. eCollection 2017.
引用本文的文献
1
Comparison of Time Within Therapeutic Range Using Anti-Factor Xa Versus Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin in Children.使用抗Xa因子与活化部分凝血活酶时间监测儿童普通肝素时治疗范围内时间的比较。
J Pediatr Pharmacol Ther. 2023;28(3):228-234. doi: 10.5863/1551-6776-28.3.228. Epub 2023 Jun 2.
2
Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran.用于儿童静脉血栓栓塞症的直接口服抗凝剂：已批准产品利伐沙班和达比加群的综述
Front Pediatr. 2022 Oct 13;10:1005098. doi: 10.3389/fped.2022.1005098. eCollection 2022.
3
Case Report: Splanchnic Vein Thrombosis as a Complication of Necrotizing Acute Pancreatitis in a Pediatric Patient.病例报告：一名儿科患者坏死性急性胰腺炎并发内脏静脉血栓形成
Front Surg. 2022 Apr 1;9:747671. doi: 10.3389/fsurg.2022.747671. eCollection 2022.
4
Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous Thromboembolism.群体药代动力学分析在儿童静脉血栓栓塞症患者中的达肝素钠。
J Clin Pharmacol. 2021 Feb;61(2):172-180. doi: 10.1002/jcph.1716. Epub 2020 Aug 21.
5
A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting.一种用于在急诊室环境中检测直接口服抗凝剂（利伐沙班和阿哌沙班）的新测试。
Crit Care Explor. 2019 Aug 20;1(8):e0024. doi: 10.1097/CCE.0000000000000024. eCollection 2019 Aug.
6
Mesenteric venous thrombosis as a complication of appendicitis in an adolescent: A case report and literature review.青少年阑尾炎并发肠系膜静脉血栓形成：一例报告及文献复习
Medicine (Baltimore). 2019 Nov;98(48):e18002. doi: 10.1097/MD.0000000000018002.
7
Direct Oral Anticoagulants: Novel Approach for the Treatment of Thrombosis in Pediatric Patients?直接口服抗凝剂：治疗儿科患者血栓形成的新方法？
Pediatr Cardiol. 2019 Oct;40(7):1431-1438. doi: 10.1007/s00246-019-02159-3. Epub 2019 Jul 20.
8
Venous thromboembolism risk factors in a pediatric trauma population.儿科创伤人群中的静脉血栓栓塞风险因素
Pediatr Surg Int. 2019 Apr;35(4):487-493. doi: 10.1007/s00383-018-4418-y. Epub 2018 Nov 19.
9
Intramural Bowel Hematoma Presenting as Small Bowel Obstruction in a Patient on Low-Molecular-Weight Heparin.低分子量肝素治疗患者中表现为小肠梗阻的肠壁内肠血肿
Case Rep Pediatr. 2018 Jun 13;2018:8780121. doi: 10.1155/2018/8780121. eCollection 2018.
10
Sepsis in a Child with Deep Venous Thrombosis - A Case Report.一名患有深静脉血栓形成的儿童的脓毒症——病例报告
J Crit Care Med (Targu Mures). 2018 Feb 9;4(1):29-33. doi: 10.1515/jccm-2018-0004. eCollection 2018 Jan.
本文引用的文献
1
Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review With Meta-Analysis.长期低分子量肝素对非妊娠成人骨折和骨密度的影响：一项荟萃分析的系统评价
J Gen Intern Med. 2016 Aug;31(8):947-57. doi: 10.1007/s11606-016-3603-8. Epub 2016 Feb 19.
2
UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis.UNBLOCK 研究：比伐卢定治疗儿童深静脉血栓的开放标签、剂量探索、药代动力学和安全性研究。
J Thromb Haemost. 2015 Sep;13(9):1615-22. doi: 10.1111/jth.13057. Epub 2015 Aug 6.
3
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.儿童和青年血栓形成治疗持续时间的多中心随机对照试验（儿童-DOTT试验）：试点/可行性阶段结果
J Thromb Haemost. 2015 Sep;13(9):1597-605. doi: 10.1111/jth.13038. Epub 2015 Aug 11.
4
Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system.儿童肝素诱导的血小板减少症：患病率、血栓形成风险和 4Ts 评分系统的应用。
J Pediatr. 2015 Jan;166(1):144-50. doi: 10.1016/j.jpeds.2014.09.017. Epub 2014 Oct 14.
5
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.新生儿和儿童的抗血栓治疗：抗血栓治疗和血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308.
6
Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.2001年至2007年美国儿童医院静脉血栓栓塞症显著增加。
Pediatrics. 2009 Oct;124(4):1001-8. doi: 10.1542/peds.2009-0768. Epub 2009 Sep 7.
7
Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levels.评估婴儿和儿童的依诺肝素给药需求。优化给药以达到治疗水平。
Thromb Haemost. 2009 Jan;101(1):86-92.
8
In vivo age dependency of unfractionated heparin in infants and children.普通肝素在婴幼儿体内的年龄依赖性
Thromb Res. 2009 Mar;123(5):710-4. doi: 10.1016/j.thromres.2008.07.009. Epub 2008 Sep 30.
9
Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates.依诺肝素用于新生儿血栓形成：呼吁为新生儿使用更高剂量
Thromb Res. 2008;122(6):826-30. doi: 10.1016/j.thromres.2007.11.009. Epub 2008 Jan 18.
10
Developmental haemostasis. Impact for clinical haemostasis laboratories.发育性止血。对临床止血实验室的影响。
Thromb Haemost. 2006 Feb;95(2):362-72. doi: 10.1160/TH05-01-0047.
Zotero 插件